Diametrics Medical receives new financing
This article was originally published in Clinica
Executive Summary
The critical care company, Diametrics Medical, has secured a further $1.5m to finance the expansion of its continuous monitoring business. The funds were raised from the sale of 15,000 shares of preferred stock and warrants, of which 10,000 shares were purchased by Mercator Advisory Group (MAG) and its affiliated funds and 5,000 by BCC Acquisition II.